Amouyal Philippe — SEC Form 4 filings
SEC reporting owner CIK 1376854. 9 Form 4 filings on record with FilingPulse; latest filed 2026-06-24.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-04-29 to 2026-06-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | Director | 6 | — | — | 12 |
| CAVA GROUP, INC. (CAVA) | Director | 3 | — | — | 3 |
Form 4 filings — Amouyal Philippe
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-24 | 4 | CAVA GROUP, INC. (CAVA) | Grant/award (A): 1,881 @ $0 | EDGAR |
| 2026-06-04 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Option exercise (M): 89,312 @ $0 · Option exercise (M): 89,312 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Grant/award (A): 35,714 (derivative) @ $0 · Grant/award (A): 43,478 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | CAVA GROUP, INC. (CAVA) | Grant/award (A): 1,767 @ $0 | EDGAR |
| 2025-06-03 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Grant/award (A): 103,806 (derivative) @ $0 · Grant/award (A): 89,312 (derivative) @ $0 | EDGAR |
| 2025-05-13 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Option exercise (M): 36,810 @ $0 · Option exercise (M): 36,810 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | CAVA GROUP, INC. (CAVA) | Grant/award (A): 1,307 @ $0 | EDGAR |
| 2024-05-13 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Grant/award (A): 44,906 (derivative) @ $0 · Grant/award (A): 36,810 (derivative) @ $0 | EDGAR |
| 2024-04-29 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Option exercise (M): 8,032 @ $0 · Option exercise (M): 8,032 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1376854 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →